Emicizumab-kxwh and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Emicizumab-kxwh and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh-Insulin glulisine
- Emicizumab-kxwh-Insulin Glulisine (Cartridges and Pens)
- Emicizumab-kxwh-Insulin Glulisine (Vials)
- Emicizumab-kxwh-Insulin glulisine Subcutaneous
- Emicizumab-kxwh-Insulin human inhaled Inhalation
- Emicizumab-kxwh-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Emicizumab-kxwh Subcutaneous
- Insulin glargine, recombinant Subcutaneous-Emla
- Insulin glargine, recombinant Subcutaneous-Emla Topical
- Insulin glargine, recombinant Subcutaneous-Emo-Cort Scalp Solution Topical application
- Insulin glargine, recombinant Subcutaneous-Emo-Cort Topical application
- Insulin glargine, recombinant Subcutaneous-Emoquette